Cerebrovascular disease in type 2 diabetes

International Congress Series

Volumn 1303, Issue , 2007, Pages 65-69

  Laakso, Markku ^a   Kuusisto, Johanna ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cerebrovascular disease; Hyperglycaemia; Type 2 diabetes

Indexed keywords

EID: 34447628189     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2007.03.017     Document Type: Article

References (25)

1. Laakso M. Insulin resistance and coronary heart disease. Curr. Opin. Lipidol. 7 (1996) 217-226
2. Pyörälä K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes/Metabolism Rev. 3 (1987) 463-524
3. Baker A.B., Kinnard J., and Iannone A. Cerebrovascular disease: VIII. Role of nutritional factors. Neurology 13 (1963) 486-491
4. Grunnet M.L. Cerebrovascular: diabetes and cerebral atherosclerosis. Neurology 13 (1963) 486-491
5. Idris I., Thompson G.A., and Sharma J.C. Diabetes mellitus and stroke. Int. J. Clin. Pract. 60 (2006) 48-56
6. You R.X., et al. Risk factors for stroke due to cerebral infarction in young adults. Stroke 28 (1997) 1913-1918
7. Hankey G.J., et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 29 (1998) 2491-5000
8. Tuomilehto J., et al. Diabetes mellitus as a risk factor for death from stroke. Stroke 27 (1996) 210-215
9. Luchsinger J.A., et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154 (2001) 635-641
10. Folsom A.R., et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 22 (1999) 1077-1083
11. Sacco R.L., et al. High-density lipoprotein cholesterol and ischemic stroke in patients with diagnosed with TIA. Neurology 28 (2001) 280-285
12. Pyörälä M., et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 538-544
13. Salmenniemi U., et al. Multiple abnormalities in glucose and energy metabolism, and coordinated changes in levels of adiponectin, cytokines and adhesion molecules in subjects with the metabolic syndrome. Circulation 110 (2004) 3842-3848
14. Kuusisto J., et al. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25 (1994) 1157-1564
15. Beckman J.A., and Creager M.A. Diabetes and atherosclerosis. Epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
16. Vinik A.I., et al. Platelet dysfunction in type 2 diabetes. Diabetes Care 24 (2001) 1476-1485
17. Stevens R.J., et al. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. UKPDS 66. Diabetes Care 27 (2004) 201-207
18. Lehto S., et al. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27 (1996) 63-68
19. Miettinen H., et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27 (1996) 2033-2039
20. Davis T.M., et al. Risk factors for stroke in type 2 diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch. Intern. Med. 159 (1999) 1097-1103
21. Sowers J.R. Treatment of hypertension in patients with diabetes. Arch. Intern. Med. 164 (2004) 1850-1857
22. Cholesterol Treatment Trialist' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
23. Stettler C., et al. Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am. Heart. J. 152 (2006) 27-38
24. Dormandy J.A., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
25. Coldwell JA. Aspirin therapy in diabetes. Diabetes Care (2004) S72-S73 27 (Suppl)